Q4 2024 Earnings Call Transcript February 19, 2025 Outset Medical, Inc. beats earnings expectations. Reported EPS is $-0.37, ...

Welcome to the Outset Medical fourth-quarter 2024 earnings conference call. (Operator Instructions) Please be advised today's conference is being recorded. I would now like to hand the conference over ...

Outset Medical (Nasdaq: OM) shares got a boost today on fourth-quarter results that topped the consensus forecast on Wall ...

Outset Medical (OM) reports Q4 2024 revenue growth, improved margins, & reduced expenses. Learn about 2025 growth plans & profitability focus.

Outset Medical Inc (OM) reports sequential revenue growth, improved gross margins, and a strengthened balance sheet, despite challenges in console sales and manufacturing overhead.

In a report released today, Rick Wise from Stifel Nicolaus maintained a Buy rating on Outset Medical (OM – Research Report), with a price ...

RBC Capital analyst Shagun Singh Chadha maintained a Hold rating on Outset Medical (OM – Research Report) yesterday and set a price target of ...

During the fourth quarter, Outset Medical made significant progress. Gross margin, essential for profitability, improved dramatically. It reached 37.7%, reflecting operational efficiencies compared to ...

Outset Medical (Nasdaq: OM) announced today that the FDA says it addressed all issues cited in a 2023 warning letter.

Outset Medical, Inc. (Nasdaq: OM) ("Outset"), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity ...

Wall Street analysts said current tariffs should be “manageable” for the sector but cautioned that other countries may ...